Vision Eye Institute Limited is at this time anticipated to have takeover price of 10.49 M with market capitalization of 10.49 M, debt of 80.92 M, and cash on hands of 12.6 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Vision fundamentals before making investing decisions based on the enterprise value of the company
Vision Investor Information
The company has Price to Book (P/B) ratio of 0.19. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vision Eye Institute Limited had not issued any dividends in recent years. Vision Eye Institute Limited, together with its subsidiaries, offer private ophthalmic services in Australia. For more information please call CA BBus at 61 3 8844 4000 or visit http://www.visioneyeinstitute.com.au.
Vision Asset UtilizationVision Eye Institute utilizes its assets roughly 8.09 %, earning A$0.08 for each dollar of assets held by the company. An increasing assets utilization denotes the company is being more effective with each dollar of assets it has. In other words assets utilization of Vision shows how effective it operates for each dollar spent on its assets
Vision Profitability Analysis
The company reported revenue of 109.43 M. Net Income was 9.39 M with profit before overhead, payroll, taxes, and interest of 39 M.
Vision Debt Analysis
VISION GROUP HLDG has accumulated about 12.6 M in cash with 24.47 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Vision Market ShareVision Eye Institute Limited is rated below average in market capitalization category among related companies. Market capitalization of Hospitals industry is at this time estimated at about 14.79 Billion. Vision adds roughly 10.49 Million in market capitalization claiming only tiny portion of equities under Hospitals industry.
Based on latest financial disclosure Vision Eye Institute Limited reported 109.43 M of revenue. This is 97.63% lower than that of Healthcare sector, and 98.01% lower than that of Hospitals industry, The Revenue for all stocks is 98.63% higher than the company.